Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Schiff

Orthopaedic Surgery Maywood, IL Medical Doctor

NPI 1457515033 CMS profile 21075

2160 S 1St Ave, Maywood, IL 60153

Open in the dashboard

General payments

$806,345

714 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$14,025

1 holding reported · through program year 2025

Through program year 2025, Adam Schiff of Maywood, IL is reported in the CMS Open Payments database as having received $806,345 across 714 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $14,025 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $149,959 95
2024 General $143,352 137
2023 General $160,401 146
2022 General $203,845 145
2021 General $35,542 97
2020 General $33,490 36
2019 General $79,756 58
2025 Ownership $14,025 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Schiff
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Adam Schiff were reported at $149,959. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Adam Schiff Orthopaedic Surgery median Middle half National median
2019 $79,756 $644 $140–$2,844 $163
2020 $33,490 $312 $75–$1,860 $114
2021 $35,542 $520 $117–$2,495 $132
2022 $203,845 $598 $128–$2,731 $149
2023 $160,401 $461 $128–$2,264 $160
2024 $143,352 $497 $134–$2,475 $164
2025 $149,959 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $380,274 348 payments
  2. MedShape, Inc. $241,708 189 payments
  3. Trilliant Surgical LLC. $132,288 108 payments
  4. Encore Medical, LP $25,283 29 payments
  5. Ipsen Bioscience Inc $9,966 5 payments
  6. RTI Surgical, Inc. $6,072 3 payments
  7. restor3d, inc. $4,094 11 payments
  8. Novastep Inc. $4,049 4 payments
  9. New Standard Device, LLC dba Metalogix $1,000 1 payment
  10. RTI Surgical, Inc $700 1 payment
  11. Other $912 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $676,701 233 payments
  2. Travel and Lodging $81,561 243 payments
  3. Royalty or License $35,901 9 payments
  4. Food and Beverage $12,181 229 payments
Products named General payments · program years 2019–2025
  1. DynaNail Helix, Washer, 15 mm $193,829 102 payments
  2. DynaNail $143,176 117 payments
  3. PROPHECY $92,003 32 payments
  4. DynaClip Bone Fixation System, Quattro, 22mm x 20mm x 20mm $70,452 49 payments
  5. HOFFMANN $59,868 22 payments
  6. PROSTEP $57,067 37 payments
  7. STAR $55,929 45 payments
  8. Arsenal Sinus Support Plate $53,530 37 payments
  9. INBONE $53,370 23 payments
  10. INFINITY $50,786 37 payments
  11. Other $461,303 372 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Orthopedic Surgery: 203

Drug cost

$37

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ibuprofen Generic 14 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$137,762

Medicare's payments for the services billed

Medicare patients

286

Average age 72

Services billed

740

180 women, 106 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Diabetes 34%
Ischemic heart disease 31%
Depression 25%
Osteoporosis 23%
Heart failure 19%
Chronic kidney disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

714 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record